Skip to Content
MilliporeSigma
  • Crystal structure of the human BRD2 bromodomain: insights into dimerization and recognition of acetylated histone H4.

Crystal structure of the human BRD2 bromodomain: insights into dimerization and recognition of acetylated histone H4.

The Journal of biological chemistry (2006-12-07)
Yoshihiro Nakamura, Takashi Umehara, Kazumi Nakano, Moon Kyoo Jang, Mikako Shirouzu, Satoshi Morita, Hiroko Uda-Tochio, Hiroaki Hamana, Takaho Terada, Naruhiko Adachi, Takehisa Matsumoto, Akiko Tanaka, Masami Horikoshi, Keiko Ozato, Balasundaram Padmanabhan, Shigeyuki Yokoyama
ABSTRACT

The BET (bromodomains and extra terminal domain) family proteins recognize acetylated chromatin through their bromodomain and act as transcriptional activators. One of the BET proteins, BRD2, associates with the transcription factor E2F, the mediator components CDK8 and TRAP220, and RNA polymerase II, as well as with acetylated chromatin during mitosis. BRD2 contains two bromodomains (BD1 and BD2), which are considered to be responsible for binding to acetylated chromatin. The BRD2 protein specifically recognizes the histone H4 tail acetylated at Lys12. Here, we report the crystal structure of the N-terminal bromodomain (BD1, residues 74-194) of human BRD2. Strikingly, the BRD2 BD1 protein forms an intact dimer in the crystal. This is the first observation of a homodimer among the known bromodomain structures, through the buried hydrophobic core region at the interface. Biochemical studies also demonstrated BRD2 BD1 dimer formation in solution. The two acetyllysine-binding pockets and a negatively charged secondary binding pocket, produced at the dimer interface in BRD2 BD1, may be the unique features that allow BRD2 BD1 to selectively bind to the acetylated H4 tail.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Nα-Acetyl-L-lysine